Craig Eagle - 01 Oct 2023 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role: Chief Medical Officer
Signature: /s/ John G. Saia, as attorney-in-fact for Craig Eagle
Issuer symbol: GH
Transactions as of: 01 Oct 2023
Transactions value $: -$70,276
Form type: 4
Date filed: 02 Oct 2023, 17:18
Previous filing: 13 Jun 2023
Next filing: 15 Dec 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GH	COMMON STOCK	Options Exercise	$0	+6.86K	+140.98%	$0.00	11.7K	01 Oct 2023	Direct
transaction	GH	COMMON STOCK	Tax liability	-$70.3K	-2.37K	-20.23%	$29.64	9.35K	01 Oct 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GH	RESTRICTED STOCK UNITS	Options Exercise	$0	-6.86K	-25%	$0.00	20.6K	01 Oct 2023	COMMON STOCK	6.86K	$0.00	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2	This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.
F3	Not applicable to Restricted Stock Units.